Literature DB >> 31926095

Predictors of non-alcoholic fatty liver disease (NAFLD) among children with obesity.

Rashdan Zaki Mohamed1, Muhammad Yazid Jalaludin2, Azriyanti Anuar Zaini2.   

Abstract

Introduction The prevalence of childhood obesity and its related comorbidities in Malaysia are alarming. Malaysia ranked second in childhood obesity among South-east Asian countries with a prevalence of 12.7%. This study was conducted to investigate the prevalence of non-alcoholic fatty liver disease (NAFLD) among obese children and to ascertain the predictors associated with NAFLD. Methods NAFLD was diagnosed via ultrasonographic evidence of fatty liver in obese and overweight children who presented to the Paediatric Obesity Clinic of University Malaya Medical Centre (UMMC), Malaysia. Demographic, anthropometric, clinical and biochemical parameters were analysed and compared between the NAFLD and non-NAFLD groups. Statistical analyses were carried out. Results Twenty-one out of 33 obese and overweight children (63.6%) were found to have NAFLD. We found that 62% of our study population in the NAFLD group had metabolic syndrome based on the definition by the International Diabetes Federation (IDF). Mean body mass index (BMI), waist circumference (WC), triglyceride (TG) and alanine aminotransferase (ALT) were found to be significantly greater in the NAFLD group compared to the non-NAFLD group (35.2 [6.1] vs. 29.3 [4.7] kg/m2 [p-value 0.007]; 104.1 [11.4] vs. 94.1 [12] cm [p-value 0.034]; 1.5 [0.9] vs. 0.9 [0.3] mmol/L [p-value 0.002]; 60.7 [53.8] vs. 27.3 [13] U/L [p-value 0.007]). Multivariate regression analysis revealed TG as the independent predictor for NAFLD, with an odds ratio of 41.7 (95% confidence interval [CI] 0.001, 0.819) (p-value 0.04). Conclusions Prevalence of NAFLD among children who are obese and overweight is alarming with 62% having metabolic syndrome. TG was found to be a strong predictor for NAFLD.

Entities:  

Keywords:  BMI; childhood obesity; non-alcoholic fatty liver disease (NAFLD); paediatric; ultrasonography

Year:  2020        PMID: 31926095     DOI: 10.1515/jpem-2019-0403

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  5 in total

1.  Alterations in DNA methylation associate with fatty liver and metabolic abnormalities in a multi-ethnic cohort of pre-teenage children.

Authors:  Cynthia A Moylan; Alisha M Mavis; Dereje Jima; Rachel Maguire; Mustafa Bashir; Jeongeun Hyun; Melanie N Cabezas; Alice Parish; Donna Niedzwiecki; Anna Mae Diehl; Susan K Murphy; Manal F Abdelmalek; Cathrine Hoyo
Journal:  Epigenetics       Date:  2022-02-21       Impact factor: 4.861

Review 2.  Possible Hepatoprotective Effect of Tocotrienol-Rich Fraction Vitamin E in Non-alcoholic Fatty Liver Disease in Obese Children and Adolescents.

Authors:  Farah D R Al-Baiaty; Aziana Ismail; Zarina Abdul Latiff; Khairul Najmi Muhammad Nawawi; Raja Affendi Raja Ali; Norfilza Mohd Mokhtar
Journal:  Front Pediatr       Date:  2021-07-08       Impact factor: 3.418

3.  Hesperidin suppresses ERS-induced inflammation in the pathogenesis of non-alcoholic fatty liver disease.

Authors:  Qi Xie; Shuqing Gao; Min Lei; Zengning Li
Journal:  Aging (Albany NY)       Date:  2022-02-10       Impact factor: 5.682

4.  Diet Containing Soy Protein Concentrate With Low and High Isoflavones for 9 Weeks Protects Against Non-alcoholic Fatty Liver Steatosis Using Obese Zucker Rats.

Authors:  Reza Hakkak; Beverly Spray; Elisabet Børsheim; Soheila Korourian
Journal:  Front Nutr       Date:  2022-06-22

Review 5.  Benefits of Physical Exercise as Approach to Prevention and Reversion of Non-Alcoholic Fatty Liver Disease in Children and Adolescents with Obesity.

Authors:  Valeria Calcaterra; Vittoria Carlotta Magenes; Matteo Vandoni; Clarissa Berardo; Luca Marin; Alice Bianchi; Erika Cordaro; Giustino Simone Silvestro; Dario Silvestri; Vittoria Carnevale Pellino; Cristina Cereda; Gianvincenzo Zuccotti
Journal:  Children (Basel)       Date:  2022-08-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.